M&A - Oncocyte Corp

Form Type: 8-K

Filing Date: 2025-06-17

Corporate Action: Merger

Type: New

Accession Number: 000164117225015338

Filing Summary: On June 13, 2025, Oncocyte Corp changed its name to Insight Molecular Diagnostics Inc. as part of a merger of its wholly-owned subsidiary with and into itself, with the company as the surviving entity. In conjunction with this name change, the company filed a Certificate of Ownership to amend its Articles of Incorporation and updated its bylaws to reflect the new name. The trading symbol for its common stock will change from 'OCX' to 'IMDX' effective June 18, 2025. The name change does not affect the rights of the company’s security holders and did not require shareholder approval. A press release and a letter to shareholders were issued on June 17, 2025, announcing the name and symbol changes, with further details available in associated exhibits.